WEST PHARM.SVCS DL-,25/ US9553061055 /
| 25/07/2024 11:32:05 | Chg. +2.000 | Volume | Bid18:39:44 | Demandez à18:39:44 | Capitalisation boursière | Dividende Y. | Rapport P/E |
|---|---|---|---|---|---|---|---|
| 295.500EUR | +0.68% | 65 Chiffrre d'affaires: 19,207.500 |
262.600Bid taille: 2,000 | 267.100Ask la taille: 2,000 | 19.31 Mrd.EUR | - | - |
Description de l'entreprise
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia.
Conseil d'administration & Conseil de surveillance
| PDG |
|---|
| Eric M. Green |
| Conseil d'administration |
| Bernard J. Birkett, Annette F. Favorite, Chris Ryan, Cindy Reiss-Clark, Dr. Quintin Lai, Kimberly Banks MacKay, Silji Abraham, Kathy dePadua |
| Conseil de surveillance |
| Eric M. Green, Deborah Keller, Douglas A. Michels, Mark Buthman, Molly E. Joseph, Myla Lai-Goldman, M.D., Paolo Pucci, Robert Friel, Thomas W. Hofmann, Stephen Lockhart, William F. Feehery |
Données de l'entreprise
| Nom: | West Pharmaceutical Services Inc. |
| Adresse: | 530 Herman O. West Drive,Exton, PA 19341-0645, USA |
| Téléphone: | +1-610-594-2900 |
| Fax: | - |
| Courriel: | west.pharmaceutical....rma.com west.pharmaceutical.services@westpharma.com |
| Internet: | www.westpharma.com |
| Industrie: | Healthcare |
| Secteur: | Pharmaceutical Industry |
| Sous-secteur: | Pharmaceuticals |
| Fin de l'exercice financier: | 31/12 |
| Flotte libre: | 67.50% |
| IPO date: | - |
Relations avec les investisseurs
| Nom: | Dr. Quintin Lai |
| Téléphone IR: | +1-610-594-3318 |
| IR-Fax: | - |
| E-mail IR: | Quintin.Lai@westpharma.com |
Calendrier de l'entreprise
| CW 30 | 25/07/2024 Interim Report 2nd Quarter/6 Months |
| CW 31 | 31/07/2024 Ex-Dividend |
| CW 31 | 31/07/2024 Record Date |
| CW 32 | 07/08/2024 Dividend Payment |
Principaux actionnaires
| Autres | 52.01% | |
| Vanguard Group Inc | 12.12% | |
| Blackrock Inc. | 10.79% | |
| Bank Of New York Mellon Corporation | 4.59% | |
| State Street Corporation | 4.43% | |
| Price (T.Rowe) Associates Inc | 3.84% | |
| Apg Asset Management N.V. | 3.06% | |
| Franklin Resources, Inc. | 2.94% | |
| T. Rowe Price Investment Management, Inc. | 2.34% | |
| Autres | 3.88% |
